Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

Ovarian health is often overlooked until symptoms become uncomfortable or difficult to ignore. Many women hear about ovarian cysts and ovarian cancer and assume they are similar because both affect ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

Our fraught national debate over immunization and public health has overshadowed some extremely encouraging advances being made by researchers in the decades-long battle against cancer. Recent news of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan Kettering, ...

Add Yahoo as a preferred source to see more of our stories on Google. New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology. By Rebecca Robbins and Gina Kolata Two treatments being tested ...

Tom has a master’s degree in biochemistry from the University of Oxford and his interests range from immunology and microscopy to the philosophy of science.View full profile Tom has a master’s degree ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Revolution Medicines thinks it could transform the treatment of pancreatic cancer – one of the hardest forms to treat – based on phase 3 data with its pan-RAS(on) inhibitor daraxonrasib. The company ...